Millennium Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Millennium Management's BEAM Position: Q3 2026 in Review
Millennium Management reduced its Beam Therapeutics (BEAM) stake by 34% in Q3 2026, selling an estimated $321K and leaving 22,725 shares worth $556K. The position accounts for ﹤0.01% of the portfolio, ranked #4954.
Millennium Management first reported a position in BEAM in Q1 2020 and has held it in 26 quarters since. The position peaked at $33.1M in Q1 2022. 264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Millennium Management held 22,725 shares of Beam Therapeutics worth $556K as of Q3 2026.
- Millennium Management sold 11,535 Beam Therapeutics shares in Q3 2026, an estimated $321K.
- Beam Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4954 holding.
- Millennium Management first reported a position in Beam Therapeutics in Q1 2020 and has held it in 26 quarters since.
- Millennium Management's Beam Therapeutics position peaked at $33.1M in Q1 2022.
- 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.